M. U. Rabbani

Evaluation of IFN- γ, Inflammatory Marker And Infectious Etiology As Risk Factors For Coronary Artery Disease

Richa Gupta, M. Azam, M. Rabbani, 2018 .

Angiographic outcomes in STEMI patients receiving fibrinolysis with guideline directed optimal antithrombotic therapy

A. Hasan, M. U. Rabbani, Shazia Durdana, 2020, Indian heart journal.

Acute and chronic Chlamydia pneumoniae infection and inflammatory markers in coronary artery disease patients.

A. Malik, M. Rizvi, Mehvash Haider, 2011, Journal of infection in developing countries.

Prevalence of nonalcoholic fatty liver disease (NAFLD) in patients of cardiovascular diseases and its association with hs-CRP and TNF-α.

N. Abdali, M. U. Rabbani, M. Ajmal, 2014, Indian heart journal.

Vitamin D levels and its supplementation in patients of heart failure

A. Hasan, S. S. Siddiqi, M. U. Rabbani, 2017 .

Role of CMV & Interferon-γ in Myocardial Infarction, Angina and Hypertension

Azam, A. Malik, M. Rizvi, 2015 .

Acute and chronic Chlamydia pneumoniae infection and inflammatory markers in coronary artery disease patients.

A. Malik, M. Rizvi, Mehvash Haider, 2011, Journal of infection in developing countries.

A study of heart rate variability and QT dispersion in patients of acute ST elevation myocardial infarction.

M. U. Rabbani, M. Zaheer, A. Wahab, 2009, Indian heart journal.